Showing results (51-60 of 149) with videos related to

Sort By:
Pageof 15
Plos Pathogens|August 15, 2014
Histone deacetylase inhibitors impair the elimination of HIV-infected cells by cytotoxic T-lymphocytesRichard Brad Jones, Rachel O'Connor, Stefanie Mueller, et al.
Plos One|July 26, 2016
Correction: Rapid Progressing Allele HLA-B35 Px Restricted Anti-HIV-1 CD8+ T Cells Recognize Vestigial CTL EpitopesChristian B Willberg, Keith E Garrison, R Brad Jones, et al.
Plos One|April 28, 2010
Rapid progressing allele HLA-B35 Px restricted anti-HIV-1 CD8+ T cells recognize vestigial CTL epitopesChristian B Willberg, Keith E Garrison, R Brad Jones, et al.
Research Square|June 10, 2024
Limited Immunogenicity of an HLA-A*03:01-restricted Epitope of Erv-k-env in Non-hiv-1 Settings: Implications for Adoptive Cell Therapy in CancerErin E Grundy, Lauren C Shaw, Loretta Wang, et al.
International Journal of Nanomedicine|July 31, 2023
Nanodepots Encapsulating a Latency Reversing Agent and Broadly Neutralizing Antibody Enhance Natural Killer Cell Cytotoxicity Against an in vitro Model of Latent HIVJoshua Ghofrani, Allan Bowen, Jie Chen, et al.
JCI Insight|October 5, 2018
Dual TLR2 and TLR7 agonists as HIV latency-reversing agentsAmanda B Macedo, Camille L Novis, Caroline M De Assis, et al.
Molecular Therapy. Methods & Clinical Development|October 2, 2020
Engineered Antigen-Specific T Cells Secreting Broadly Neutralizing Antibodies: Combining Innate and Adaptive Immune Response against HIVAllison B Powell, Yanqin Ren, Maria Korom, et al.
Journal of Virology|January 11, 2019
Establishment of a Novel Humanized Mouse Model To Investigate <i>In Vivo</i> Activation and Depletion of Patient-Derived HIV Latent ReservoirsNina C Flerin, Ariola Bardhi, Jian Hua Zheng, et al.
Journal of Virology|June 26, 2009
Human immunodeficiency virus type 1 escapes from interleukin-2-producing CD4+ T-cell responses without high-frequency fixation of mutationsR Brad Jones, Feng-Yun Yue, Xiao Xiao Jenny Gu, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 3, 2019
Brief Report: HIV Antibodies Decline During Antiretroviral Therapy but Remain Correlated With HIV DNA and HIV-Specific T-Cell ResponsesSheila M Keating, Richard Brad Jones, Christina M Lalama, et al.
Pageof 15